miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of molecular medicine

• Publication date

  2017-05-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00109-017-1539-zPMID 28487996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2.

  2016cited by this paper
• miR-30 family promotes migratory and invasive abilities in CD133+ pancreatic cancer stem-like cells

  2016cited by this paper
• The IL-1β/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis

  2016cited by this paper
• MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression

  2016cited by this paper
• Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway

  2016cited by this paper
• miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage

  2016cited by this paper
• MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT).

  2016cited by this paper
• Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control

  2015cited by this paper
• MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.

  2015cited by this paper
• Micro‐RNA‐30a regulates ischemia‐induced cell death by targeting heat shock protein HSPA5 in primary cultured cortical neurons and mouse brain after stroke

  2015cited by this paper
• Inhibition of Autophagy by MiR-30A Induced by Mycobacteria tuberculosis as a Possible Mechanism of Immune Escape in Human Macrophages.

  2015cited by this paper
• Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel

  2015cited by this paper
• MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.

  2015cited by this paper
• The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

  2015cited by this paper
• The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2

  2015cited by this paper
• The miR-30 Family Inhibits Pulmonary Vascular Hyperpermeability in the Premetastatic Phase by Direct Targeting of Skp2

  2015cited by this paper
• miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

  2015cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Cell-Penetrating, Guanidinium-Rich Molecular Transporters for Overcoming Efflux-Mediated Multidrug Resistance

  2014cited by this paper
• Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein

  2014cited by this paper
• miR-17-5p Downregulation Contributes to Paclitaxel Resistance of Lung Cancer Cells through Altering Beclin1 Expression

  2014cited by this paper
• Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling

  2014cited by this paper
• MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.

  2014cited by this paper
• Cancer cell resistance mechanisms: a mini review

  2014cited by this paper
• miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.

  2014cited by this paper
• The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin

  2014cited by this paper
• miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

  2013cited by this paper
• MicroRNAs: novel mediators of resistance to microtubule-targeting agents.

  2013cited by this paper
• Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

  2013cited by this paper
• Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK)*

  2012cited by this paper
• Src family kinases and paclitaxel sensitivity

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.

  2009cited by this paper
• Functional Analysis of 11 q 13 . 5 Amplicon Identifies Rsf-1 ( HBXAP ) as a Gene Involved in Paclitaxel Resistance in Ovarian Cancer

  2009cited by this paper
• miRBase: microRNA sequences, targets and gene nomenclature

  2005cited by this paper
• Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

  2001cited by this paper
• Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.

  1993cited by this paper
• Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.

  1993cited by this paper
• Drug resistance in cancer: an overview of the clinical aspects.

  1989cited by this paper

• Shenmai Injection Reduces Cardiomyocyte Apoptosis Induced by Doxorubicin through miR-30a/Bcl-2

  2025cites this paper
• The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential

  2025influential citation
• Role of microRNAs in lung oncogenesis: Diagnostic implications, resistance mechanisms, and therapeutic strategies.

  2025cites this paper
• Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects

  2025cites this paper
• The role of the miR-30a-5p/BCL2L11 pathway in rosmarinic acid-induced apoptosis in MDA-MB-231-derived breast cancer stem-like cells

  2024cites this paper
• Prognostic value of plasma microRNAs for non-small cell lung cancer based on data mining models

  2024cites this paper
• Advancements in the Cultivation, Active Components, and Pharmacological Activities of Taxus mairei

  2024cites this paper
• The role of selected non-coding RNAs in the biology of non-small cell lung cancer.

  2023cites this paper
• Effect of IFN‑γ encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer

  2023cites this paper
• Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells

  2023cites this paper
• Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids

  2023cites this paper
• Lentinan regulates the immune efficacy of macrophage for lung metastasis in triple negative breast

  2023cites this paper
• CTHRC1 targeted by miR-30a-5p regulates cell adhesion, invasion and migration in lung adenocarcinoma

  2022cites this paper
• MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going

  2022cites this paper
• Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance

  2022cites this paper
• microRNA-Based Biomarkers in Lung Cancer: Recent Advances and potential Applications.

  2022cites this paper
• An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer

  2022cites this paper
• Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

  2022cites this paper
• Circ_0011292 knockdown mitigates progression and drug resistance in PTX‐resistant non‐small‐cell lung cancer cells by regulating miR‐433‐3p/CHEK1 axis

  2022cites this paper
• miR-30a-5p targets Becn1 to ameliorate high-glucose-induced glomerular podocyte injury in immortalized rat podocyte cell line.

  2021cites this paper
• Repertoires of MicroRNA-30 family as gate-keepers in lung cancer.

  2021cites this paper
• Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization

  2021cites this paper
• Mechanisms of resistance to chemotherapy in non-small cell lung cancer

  2021cites this paper
• MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.

  2021cites this paper
• RNA-targeting Therapy: A Promising Approach to Reach Non-Druggable Targets

  2021cites this paper
• Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.

  2021cites this paper
• Targeting Bcl-2 for cancer therapy.

  2021cites this paper
• Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer

  2021cites this paper
• Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis

  2021cites this paper
• Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.

  2020cites this paper
• Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.

  2020cites this paper
• Non-coding RNAs in Lung Cancer Chemoresistance.

  2020cites this paper
• Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis

  2020cites this paper
• Exosomes Derived From Epigallocatechin Gallate-Treated Cardiomyocytes Attenuated Acute Myocardial Infarction by Modulating MicroRNA-30a

  2020influential citation
• RETRACTED ARTICLE: The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2

  2020cites this paper
• MicroRNA-30a targets BECLIN-1 to inactivate autophagy and sensitizes gastrointestinal stromal tumor cells to imatinib

  2020cites this paper
• Genetic Variations in miR-30 Family Member Regulatory Regions Are Associated with Breast Cancer Risk in a Chinese Population

  2020cites this paper
• miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1

  2020cites this paper
• DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP

  2020cites this paper
• Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2

  2020cites this paper
• LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway

  2020cites this paper
• Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer.

  2020cites this paper
• miR-520a-3p enhances the paclitaxel sensitivity of non-small cell lung cancer A549/TAX cells by targeting FZD8

  2019influential citation
• miR‐29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1

  2019cites this paper
• Ipilimumab affects T lymphocytes and Bcl-2 mRNA expression in xenograft tissues of lung cancer-bearing mice by inhibiting TGF-β1/ERK signaling pathway

  2019cites this paper
• Down‐regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor

  2019cites this paper
• Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1), a pseudo phosphatase, promotes oncogenesis in glioma.

  2019cites this paper
• Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review

  2019cites this paper
• Trichostatin A-induced miR-30a-5p regulates apoptosis and proliferation of keloid fibroblasts via targeting BCL2

  2019influential citation
• Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy

  2019cites this paper
• Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.

  2018cites this paper
• A review of microRNAs related to the occurrence, diagnosis, and prognosis of non-small cell lung cancer

  2018cites this paper
• Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing

  2018cites this paper
• MicroRNA-21 promotes the proliferation, migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy activity via AMPK/ULK1 signaling pathway.

  2018cites this paper
• EGCG inhibits CSC‐like properties through targeting miR‐485/CD44 axis in A549‐cisplatin resistant cells

  2018influential citation
• MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

  2018cites this paper
• Analysis of change in microRNA expression profiles of lung cancer A549 cells treated with Radix tetrastigma hemsleyani flavonoids

  2018cites this paper
• Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells

  2018cites this paper
• Current updates on microRNAs as regulators of chemoresistance.

  2017cites this paper
• miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study

  2017cites this paper